clinical trial · NCT06510413
An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers
OsteoarthritisMuscle PainSwelling MuscleLoxoprofen Sodium Patches(reference product)Loxoprofen Sodium Patches(test product )
brief summary
This study was a single-center, randomized, open-label, two-agent, two-cycle, double-cross bioequivalence trial.
started
Jul 1, 2024
primary completion
Aug 1, 2024
completion
Aug 1, 2024
last updated
Jul 19, 2024
detailed description
The objectives of this study are to evaluate the difference of absorption degree and absorption rate of two kinds of patches( FB3002 vs. Loxonin®) in Chinese healthy population, and to assess the bioavailability of these two patches.
official title
An Bioequivalence Study of Loxoprofen Sodium Patches in Chinese Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol